RxE2

Committed to improving the way clinical trials are managed, making them more efficient and effective to drive more drugs to the market faster, RXE2 is focused on leveraging the power of community, and specifically community pharmacists, providing them with powerful and cutting-edge technology, so that they can help the pharmaceuticals with their challenges in clinical trials. Clinical studies traditionally take many years and cost hundreds of millions of dollars to design, run and analyze. The biggest challenges pharmaceutical companies face when it comes to clinical trials and research are usually patient recruitment (both in time and diversity), patient engagement and...

Clinical trials,patient recruitment,pharmacy,community pharmacy,patient engagement,artificial intelligence,machine learning,pharmaceuticals,drug development,drug dispensing,clinical supply chain,digital medicine,digital health,healthtech,clinical trials innovation,clinical trials quality,decentralized clinical trials,and direct to patient

Rxe2 operates in the Pharmaceutical manufacturing industry.

Rxe2's revenue is 11m - 100m

Rxe2 has 11 - 50 employees.